Form 4: Nuvalent CFO Trades Shares Under 10b5-1 Plan

Nuvalent's Chief Financial Officer, Alexandra Balcom, executed trades involving Class A Common Stock and stock options on May 1, 2026, under a pre-established Rule 10b5-1 trading plan.

Summary

• Alexandra Balcom, Chief Financial Officer of Nuvalent, Inc., reported transactions on May 1, 2026.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on December 23, 2025.
• Balcom acquired 7,159 shares of Class A Common Stock at $1.08 and 4,271 shares at $6.89.
• She also disposed of 3,872 shares at a weighted average price of $98.42, 7,434 shares at $99.29, and 124 shares at $99.97.
• Following these transactions, Balcom beneficially owns 92,692 shares directly and 96,963 shares directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the significant volume of shares sold by a key executive, despite being executed under a pre-planned 10b5-1 strategy.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned and potentially non-insider trading activity.
• Acquisition of shares at lower price points ($1.08 and $6.89) could be seen as opportunistic or part of a structured acquisition strategy within the plan.
• The reporting person continues to hold a significant number of shares after the reported disposals.

Negatives

• Significant disposal of Class A Common Stock at prices around $98-$100, indicating a reduction in direct holdings by a key executive.
• The weighted average prices for sales suggest a substantial volume of shares were sold.

Risks

• Potential for negative market perception due to a high-ranking executive selling a considerable number of shares, even if under a pre-planned 10b5-1 strategy.
• The specific prices and volumes of sales, while averaged, represent a notable divestment that could be interpreted as a lack of confidence by some investors.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025.
• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes upon request.

Industry Context

StockSavvy.ai notes that the use of Rule 10b5-1 plans is a common and accepted practice for corporate insiders to trade company stock in a manner that avoids accusations of insider trading. However, significant sales by executives, even under these plans, can still influence market perception.

Stakeholder Impact

• Shareholders may interpret the significant sales by the CFO as a signal, potentially impacting short-term stock price sentiment, despite the Rule 10b5-1 plan.
• Employees with stock options may be influenced by the executive's trading activity, though the underlying rationale is pre-planned.

Next Steps

• The reporting person may be required to provide further details on specific sale prices upon request from the SEC, Nuvalent, or a security holder.

Key Dates

Recommendation

The filing reports routine insider transactions under a 10b5-1 plan. While the sale of a significant number of shares by the CFO could be a short-term sentiment dampener, the pre-planned nature of the trades and the continued beneficial ownership suggest it's not a strong indicator of fundamental business deterioration. Therefore, a 'hold' recommendation is appropriate pending further fundamental analysis.

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Rule 10b5-1, Stock Options, Class A Common Stock, Beneficial Ownership, Alexandra Balcom, Chief Financial Officer, SEC Filing